ERISBSEEris Lifesciences LtdHighNegative
Announced Thu, 28 May · 15:41 IST

As Attached

Sebi PenaltyRegulatory & Legal View source PDF

ERIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.0%1-day move
₹1353.40
prior close
₹1350.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.2+0.8+0.3+0.7+2.0+0.6+3.0+1.1+0.5+1.3+6.8+3.5
Up moveDown movePending
AI summary

BSE and NSE have each imposed a fine of ₹4,24,800 on the company for failing to comply with Regulation 17(1) of the SEBI Listing Regulations regarding board composition for the quarter ended March 31, 2026. The non-compliance arose from a board vacancy caused by an Independent Director completing their term. The company clarified that the vacancy was filled effective March 14, 2026, restoring compliance with the regulation. The total financial impact is limited to the penalty amount of ₹8,49,600 (₹4,24,800 each from BSE and NSE), with no other operational or financial impact.

Likely market impact

Minor financial impact of ₹8.5 lakh total fine, but the company has already rectified the board composition issue since mid-March 2026, reducing the severity of the penalty for shareholders.